The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Apolipoprotein E polymorphism and atherosclerosis.
Abstract
The apo E locus contributes to determining the variation in plasma cholesterol levels of healthy and diseased populations. It also influences the expression of hyperlipidemia and appears to modulate the susceptibility to atherosclerosis in a complex multifactorial interaction. There is evidence that the presence of apo E2 is protective, whereas that of apo E4 predisposes to coronary artery disease. The burden of proof, however, lies on future, well-designed clinical trials and prospective studies. The study of the biological significance of the apo E polymorphism in humans has emphasized the importance of gene-gene and gene-environment interactions in the pathogenesis of hyperlipidemia and atherosclerosis. The apo E polymorphism involves the coding region of the apo E gene and results in alterations of the gene product which, in turn, either directly or secondarily affect the metabolic fate of the lipoprotein particles. Rapid advances in knowledge over the last decade have provided a metabolic explanation for the observation of the opposite effects of the epsilon 4 and the epsilon 2 alleles on lipoprotein levels. Apo E2 has lower receptor binding affinity which results in delayed clearance of apo E2-bearing lipoprotein particles from plasma. Apo E4 is distributed differently from apo E3 between VLDL and HDL, is degraded more rapidly than apo E3, and may enhance the catabolism of E4-bearing particles, leading to other alterations in lipoprotein metabolism which result in elevated levels of LDL. In view of the significant opposite impacts of the epsilon 4 and the epsilon 2 alleles on plasma LDL cholesterol concentrations, it is evident that determination of the apo E phenotype will become a useful adjunct to the assessment of the cardiovascular risk profile of an individual. In addition, the relationship between the epsilon 2 allele and type III hyperlipoproteinemia provides a valuable model for the study of complex genetic interactions in the pathogenesis of hyperlipidemia. The further study of apo E and its interactions shows great promise for a deeper comprehension of the pathogenesis of atherosclerosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The critical role of APOE in lipid metabolism is underscored by evidence showing that APOE2 homozygosity can lead to Hyperlipoproteinemia type III (HLP), characterized by mixed hypercholesterolemia and hypertriglyceridemia [35–39].”
In the citing paper
“This observation, coupled with evident mixed hypercholesterolemia and hypertriglyceridemia, supports the characterization of APOE2hAβ rats as a model for type III HLP”
In the citing paper
“Both the ε2 and the ε4 alleles are associated with unfavorable lipid profiles [8][9][10][11][12][13].”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [13]
In the citing paper
“It is estimated that less than one in 20 individuals with the ε22 genotype will have overt type III hyperlipoproteinemia [24].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“At the level of an individual the effect of the APOE polymorphism on plasma lipid levels is moderate, however since the APOE polymorphism is common, it contributes substantially to the total phenotypic variability in plasma lipid levels in the general population [21,24,58].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“The pattern of associations between the six common APOE genotypes and plasma lipid levels is similar across populations, although the magnitude of the associations differs between populations and subgroups within populations; thus both context-dependent and invariant associations could be suggested [9,24,30].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [24]
In the citing paper
“Both ɛ2 and ɛ4 alleles are associated with unfavourable lipid profiles,12–19”
From Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort (2019) · cites this paper as [18]
In the citing paper
“a decreased risk of coronary artery disease (unless it is associated with type III hyperlipoproteinemia), 42,43”
From Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E (1996) · cites this paper as [42]
Citations
Cites
Boyles, J. K., Pitas, R. E., Wilson, E., Mahley, R. W., & Taylor, J. M. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112130 · Cited by 829
Weisgraber, K. H., Rall, S. C., & Mahley, R. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52510-8 · Cited by 777
Lipoprotein receptors and cholesterol homeostasis
Mahley, R. W., & Innerarity, T. L. (1983) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(83)90001-1 · Cited by 756
Human apolipoprotein E. The complete amino acid sequence
Rall, S. C., Weisgraber, K. H., & Mahley, R. W. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34702-1 · Cited by 741
(1985) · PubMed · Cited by 706
Self-citationPolymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man
UTERMANN, G., HEES, M., & STEINMETZ, A. (1977) · Nature · doi:10.1038/269604a0 · Cited by 666
Zannis, V. I., & Breslow, J. L. (1981) · Biochemistry · doi:10.1021/bi00507a059 · Cited by 563
Polymorphism of apolipoprotein E
Utermann, G., Vogelberg, K. H., Steinmetz, A., Schoenborn, W., Pruin, N., Jaeschke, M., Hees, M. T. I. W. S.-V., & Canzler, H. (1979) · Clinical Genetics · doi:10.1111/j.1399-0004.1979.tb02027.x · Cited by 408
Apolipoprotein E polymorphism in health and disease
Utermann, G. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90610-7 · Cited by 389
Elshourbagy, N. A., Liao, W. S., Mahley, R. W., & Taylor, J. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.1.203 · Cited by 376
Cited by
Sorted by citations
Items 701–800 of 1,005
Vascular Smooth Muscle Actin Is Reduced in Alzheimer Disease Brain: A Quantitative Analysis
Ervin, J. F., Pannell, C., Szymanski, M. H., Welsh-Bohmer, K. A., Schmechel, D. E., & Hulette, C. M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.735 · Cited by 41
Tucker, A. J., MacKay, K. A., Robinson, L. E., Graham, T. E., Bakovic, M., & Duncan, A. M. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-37 · Cited by 41
Candidate Genes as Potential Links Between Periodontal and Cardiovascular Diseases
Kornman, K. S., & Duff, G. W. (2001) · Annals of Periodontology · doi:10.1902/annals.2001.6.1.48 · Cited by 41
Katsuya, T., Baba, S., Ishikawa, K., Mannami, T., Fu, Y., Inamoto, N., Asai, T., Fukuda, M., Higaki, J., Ogata, J., et al. (2002) · Journal of Hypertension · doi:10.1097/00004872-200210000-00021 · Cited by 41
Ahn, Y. I., Kamboh, M. I., Aston, C. E., Ferrell, R. E., & Hamman, R. F. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.5.663 · Cited by 41
Retinitis Punctata Albescens Associated With the Arg135Trp Mutation in the Rhodopsin Gene
Souied, E. H., Soubrane, G., Benlian, P., COSCAS, G. J., Gerber, S., Münnich, A., & Kaplan, J. (1996) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(14)70530-6 · Cited by 41
Apolipoprotein E phenotype is not related to late-life depression in a population-based sample
Schmand, B. A., Hooijer, C., Jonker, C., Lindeboom, J., & Havekes, L. M. (1997) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270050017 · Cited by 41
Vascular genetic factors and human longevity
Panza, F., D’Introno, A., Colacicco, A. M., Capurso, C. A., Capurso, S. A., Kehoe, P. G., Capurso, A., & Solfrizzi, V. (2004) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.12.005 · Cited by 41
Influence of apolipoprotein H polymorphism on levels of triglycerides
Cassader, M., Ruiu, G., Gambino, R., Guzzon, F., Pagano, A., Veglia, F., Pagni, R., & Pagano, G. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90066-3 · Cited by 41
Heikkinen, A. M., NISKANEN, L. K., Ryynänen, M., Komulainen, M. H., Tuppurainen, M. T., Parviainen, M. T., & Saarikoski, S. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.2.402 · Cited by 41
Snowden, C. P., Houlston, R. S., Arif, M. H., Laker, M. F., Humphries, S. E., & Alberti, K. G. M. M. (1991) · Clinica Chimica Acta · doi:10.1016/0009-8981(91)90207-s · Cited by 41
Loktionov, A., Vorster, H. H., O'Neill, I. K., Nell, T. A., Bingham, S. A., Runswick, S. A., & Cummings, J. H. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00022-2 · Cited by 40
Apolipoprotein E Genetic Polymorphism and Stroke Subtypes in a Bangladeshi Hospital-Based Study.
Chowdhury, A. H., Yokoyama, A., Kokubo, Y., Zaman, M. M., Haque, A., & Tanaka, H. (2001) · Journal of Epidemiology · doi:10.2188/jea.11.131 · Cited by 40
Grünenfelder, J., Umbehr, M., Plass, A., Bestmann, L., Maly, F. E., Zünd, G., & Turina, M. I. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.02.022 · Cited by 40
Grönroos, P. E., Raitakari, O. T., Kähönen, M. A. P., Hutri‐Kähönen, N., Marniemi, J., Viikari, J. S. A., & Lehtimäki, T. J. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.116 · Cited by 40
Apolipoprotein E polymorphism in Brazilian dyslipidemic individuals: Ouro Preto study
Mendes-Lana, A., Pena, G. D. G., de Freitas, S. N., Lima, A. A., Nicolato, R. L. D. C., do Nascimento-Neto, R. M., Machado-Coelho, G. L. L., & de Freitas, R. N. (2007) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2007000100007 · Cited by 40
Mueller, T., Fischer, J., Gessner, R. V., Rosendahl, J., Böhm, S. K., van Bömmel, F., Knop, V., Sarrazin, C., Witt, H., Marques, A. M., et al. (2016) · Liver International · doi:10.1111/liv.13094 · Cited by 40
Traykov, L. D., Rigaud, A., Baudic, S., Smagghe, A., Boller, F., & Forette, F. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00287-3 · Cited by 40
Review: The renin-angiotensin-aldosterone system and Alzheimer's disease?
Kehoe, P. G. (2003) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.3317/jraas.2003.017 · Cited by 41
Wardell, M., Rall, S., Schaefer, E., Kane, J., & Weisgraber, K. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42076-0 · Cited by 40
Apolipoprotein E and Alzheimer's disease: the implications of progress in molecular medicine.
Mayeux, R. P., & Schupf, N. (1995) · American Journal of Public Health · doi:10.2105/ajph.85.9.1280 · Cited by 40
Dallongeville, J., Tiret, L., Visvikis‐Siest, S., O’Reilly, D. S. J., Saava, M., Tsitouris, G., Rosseneu, M., DeBacker, G., Humphries, S. E., & Beisiegel†, U. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00069-6 · Cited by 40
ApoE4 polymorphism increases the risk for exercise-induced silent myocardial ischemia in older men.
Katzel, L. I., Fleg, J. L., Paidi, M., Ragoobarsingh, N., & Goldberg, A. P. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.10.1495 · Cited by 40
Finkelstein, J. M., Heemels, M.-T., Shadan, S., & Weiss, U. K. (2014) · Nature · doi:10.1038/510047a · Cited by 41
Yang, C., Tian, G., Mi, J., Wei, X., Li, X., Li, X., Wang, W., & Wang, B. (2015) · Scientific Reports · doi:10.1038/srep09495 · Cited by 39
Innate Immune and Fungal Model of Alzheimer’s Disease
Parady, B. (2018) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-180073 · Cited by 40
Jenkins, D. J. A., Kendall, C. W. C., Marchie, A., Jenkins, A. L., Connelly, P. W., Jones, P. J. H., & Vuksan, V. V. V. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/s1095-6433(02)00345-8 · Cited by 39
Beavan, S. R., Prentice, A., Stirling, D. M., Dibba, B., Yan, L., Harrington, D. J., & Shearer, M. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602037 · Cited by 39
Daimiel, L., Vargas, T., & de Molina, A. R. (2012) · Electrophoresis · doi:10.1002/elps.201200084 · Cited by 39
KALLIO, M. J. T., Salmenperä, L., Siimes, M. A., Perheentupa, J., Gylling, H., & Miettinen, T. A. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37242-4 · Cited by 39
Hérasse, M., Spentchian, M., Taillandier, A., Keppler-Noreuil, K., Fliorito, A. N. M., Bergoffen, J., Wallerstein, R., Muti, C., Simon‐Bouy, B., & Mornet, E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.605 · Cited by 39
Seet, W. T., Tan, J. A. M. A., & Yen, T. S. (2004) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.11.001 · Cited by 40
Withers, R. T., Laforgia, J., & Heymsfield, S. B. (1999) · American Journal of Human Biology · doi:10.1002/(sici)1520-6300(1999)11:2 · Cited by 86
Apolipoprotein E polymorphism and renal disease
Oda, H., Yorioka, N., Ueda, C., Kushihata, S., & Yamakido, M. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07107.x · Cited by 39
Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus
Cariolou, M. A., Kokkofitou, A., Manoli, P., Christou, S., Karagrigoriou, A., & Middleton, L. T. (1995) · Genetic Epidemiology · doi:10.1002/gepi.1370120506 · Cited by 39
Alzheimer's Disease: The apolipoprotein E connection
Utermann, G. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00081-6 · Cited by 39
Weisgraber, K. H., Newhouse, Y. M., & Mahley, R. W. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)81003-9 · Cited by 39
Hegele, R. A., Breckenridge, W. C., Cox, D. W., Maguire, G. F., Little, J. A., & Connelly, P. W. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.5.1303 · Cited by 39
Bailleul, S., Couderc, R., Rossignol, C., Fermanian, J., Boutouchent, F., Farnier, M. A., & Etienne, J. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.2.241 · Cited by 39
Jenkins, D. J. A., Hegele, R. A., Jenkins, A. L., Connelly, P. W., Hallak, K., Bracci, P. M., Kashtan, H., Corey, P., Pintilia, M., Stern, H., et al. (1993) · Metabolism · doi:10.1016/0026-0495(93)90217-c · Cited by 39
Insull, W. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420210087010 · Cited by 39
Xu, C., Talmud, P. J., Angelico, F., Ben, M. D., Savill, J., Humphries, S. E., & Vogler, G. P. (1991) · Genetic Epidemiology · doi:10.1002/gepi.1370080605 · Cited by 39
Lehtimäki, T. J., Moilanen, T. P. S., Porkka, K., Åkerblom, H. K., Rönnemaa, T., Räsänen, L., Viikari, J. S. A., Ehnholm, C., & Nikkari, T. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40051-3 · Cited by 39
Uusitupa, M., Karhunen, L. J., Rissanen, A., Franssila-Kallunki, A., NISKANEN, L. K., Kervinen, K., & Kesäniemi, Y. A. (1996) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/64.2.131 · Cited by 39
Houlden, H., Crook, R., Hardy, J., Roques, P., Collinge, J., & Rossor, M. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90026-4 · Cited by 38
Yin, R., Pan, S., Wu, J., Lin, W., & Dezhai, Y. (2008) · Experimental Biology and Medicine · doi:10.3181/0709-rm-254 · Cited by 38
Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis
Kim, J. Y., Choi, B.-G., Jelı́nek, J., Lee, S. H., Lee, S. H., Cho, K., Rha, S. H., Lee, Y. H., Jin, H. S., Choi, D.-K., et al. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-00846-0 · Cited by 38
Chang, N.-W., Chen, D., Wu, C.-T., Aouizerat, B. E., Chen, F.-N., Hung, S.-J., Wang, S.-H., Wei, M., & Chang, C. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-4656-7 · Cited by 38
Small hippocampal size in cognitively normal subjects with coronary artery disease
Koschack, J., & Irle, E. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.009 · Cited by 38
Apolipoprotein E gene polymorphism and gender.
Kolovou, G. D., Damaskos, D., Anagnostopoulou, K. K., & Cokkinos, D. V. (2009) · PubMed · Cited by 38
A Twin Study of the Genetic Contribution to Age-Related Functional Impairment
Gurland, B. J., Page, W. F., & Plassman, B. L. (2004) · The Journals of Gerontology Series A · doi:10.1093/gerona/59.8.m859 · Cited by 38
Guang-da, X., & Yuhua, W. (2003) · Diabetologia · doi:10.1007/s00125-003-1060-5 · Cited by 38
Lin, H., Lai, C., Tai, C., Lin, R., & Liu, C. (2004) · Neuroepidemiology · doi:10.1159/000075956 · Cited by 38
Henry, J. A., Bolla, M. K., Osmond, C., Fall, C. H. D., Barker, D., & Humphries, S. E. (1997) · Journal of Medical Genetics · doi:10.1136/jmg.34.7.553 · Cited by 38
Lipoprotein Transport Gene Abnormalities Underlying Coronary Heart Disease Susceptibility
Breslow, J. L. (1991) · Annual Review of Medicine · doi:10.1146/annurev.me.42.020191.002041 · Cited by 38
Efficiency of intestinal cholesterol absorption in humans is not related to apoE phenotype
von Bergmann, K., Lütjohann, D., Lindenthal, B., & Steinmetz, A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200319-jlr200 · Cited by 38
Sorlí, J. V., Corella, D., Francès, F., Sabio, J. B. R., González, J. I., Guillén, M., & Portolés, O. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.10.001 · Cited by 38
Humphries, S. E., Coviello, D. A., Masturzo, P., Balestreri, R., Orecchini, G., & Bertolini, S. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.509 · Cited by 38
Srinivasan, S. R., Ehnholm, C., Elkasabany, A., & Berenson, G. S. (2001) · Metabolism · doi:10.1053/meta.2001.23299 · Cited by 38
Sellick, G. S., Wade, R. L., Richards, S., Oscier, D. G., Catovsky, D., & Houlston, R. S. (2007) · Blood · doi:10.1182/blood-2007-08-110130 · Cited by 38
Polymorphisms of APOE and LRP Genes in Brazilian Individuals With Alzheimer Disease
Bahia, V. S., Kok, F., Marie, S. K. N., Oba‐Shinjo, S. M., Caramelli, P., & Nitríni, R. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815a9da7 · Cited by 37
Liang, S., Steffen, L. M., Steffen, B. T., Guan, W., Weir, N. L., Rich, S. S., Manichaikul, A. W., Vargas, J. D., & Tsai, M. Y. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.02.004 · Cited by 37
FOXO3 and Exceptional Longevity: Insights From Hydra to Humans
Davy, P. M. C., Allsopp, R., Donlon, T. A., Morris, B. J., Willcox, D. C., & Willcox, B. J. (2018) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.001 · Cited by 39
Shi, J., Liu, Y., Liu, Y., Li, Y., Qiu, S., Bai, Y., Gu, Y., Luo, J., Cui, H., Li, Y., et al. (2018) · Gene · doi:10.1016/j.gene.2018.06.097 · Cited by 37
HIV-1 TAT inhibits microglial phagocytosis of Abeta peptide.
(2008) · PubMed Central · Cited by 37
Lahoz, C., Osgood, D. P., Wilson, P. W., Schaefer, E. J., & Ordovás, J. M. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.11.1817 · Cited by 37
Gouni-Berthold, I., Giannakidou, E., Müller-Wieland, D., Faust, M., Kotzka, J., Berthold, H., & Krone, W. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.12.005 · Cited by 44
Altenburg, M. K., Arbonés-Mainar, J. M., Johnson, L. A., Wilder, J., & Maeda, N. (2008) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.164863 · Cited by 38
Kumar, P., Luthra, K., Dwivedi, M., Behl, V. K., Pandey, R. M., & Misra, A. (2003) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456303766477020 · Cited by 37
Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence
Drury, J., & Narayanaswami, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414019200 · Cited by 37
Capurso, C. A., Solfrizzi, V., D’Introno, A., Colacicco, A. M., Capurso, S. A., Semeraro, C., Capurso, A., & Panza, F. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.03.037 · Cited by 37
Molecular Neurobiology of Alzheimer's Disease (Syndrome?)
Zubenko, G. S. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709000303 · Cited by 37
Cardiovascular Damage in Alzheimer Disease: Autopsy Findings From the Bryan ADRC
Corder, E. H., Ervin, J. F., Lockhart, E. L., Szymanski, M. H., Schmechel, D. E., & Hulette, C. M. (2005) · BioMed Research International · doi:10.1155/jbb.2005.189 · Cited by 37
Involvement of apolipoprotein E in glioblastoma: immunohistochemistry and clinical outcome
Nicoll, J. A. R., Zunarelli, E., Rampling, R., Murray, L. S., Papanastassiou, V., & Stewart, J. (2003) · Neuroreport · doi:10.1097/00001756-200310270-00008 · Cited by 37
The role of the Maillard reaction in other pathologies: Alzheimer's disease
Colaco, C. A. L. S., Ledesma, M. D., Harrington, C. R., & Ávila, J. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.supp5.7 · Cited by 37
Afroze, D., Yousuf, A., Tramboo, N. A., Shah, Z. A., & Ahmad, A. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0389-7 · Cited by 37
The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects
Niemi, M., Kervinen, K., Rantala, A. O., Kauma, H., Päivänsalo, M. J., Savolainen, M. J., Lilja, M., & Kesäniemi, Y. A. (1999) · Gut · doi:10.1136/gut.44.4.557 · Cited by 37
Association of DNA‐haplotypes in the human LDL‐receptor gene with normal serum cholesterol levels
Schuster, H., Humphries, S. E., Rauh, G., Held, C., Keller, C., Wolfram, G., & Zöllner, N. (1990) · Clinical Genetics · doi:10.1111/j.1399-0004.1990.tb03604.x · Cited by 37
The Atherogenic Significance of an Elevated Plasma Triglyceride Level
Ooi, T. C., & Ooi, D. S. (1998) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408369891234255 · Cited by 37
GENETICS OF LIPOPROTEIN DISORDERS
Davignon, J., & Genest, J. J. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70024-4 · Cited by 37
Self-citationHackler, R., Schäfer, J., Motzny, S., Brand, S., Kleine, T. O., Kaffarnik, H., & Steinmetz, A. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40122-1 · Cited by 37
Apolipoprotein E and diets: a case of gene-nutrient interaction?
Rubin, J., & Berglund, L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00005 · Cited by 37
Aalto‐Setälä, K., Palomäki, H., Miettinen, H. E., Vuorio, A. F., Kuusi, T., Raininko, R., Salonen, O. L. M., Kaste, M., & KONTULA, K. K. (1998) · Annals of Medicine · doi:10.3109/07853899808999408 · Cited by 37
Swinkels, D. W., Demacker, P. N. M., Hendriks, J. C. M., Brenninkmeijer, B. J., & Stuyt, P. M. J. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90010-5 · Cited by 37
Zambón, D., Ros, E., Casals, E., Sanllehy, C., Bertomeu, A., & Campero, I. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.1.141 · Cited by 37
Alcohol consumption and risk of dementia
Liedholm, H., & Linné, A. B. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09650-2 · Cited by 37
Characterization of a new apolipoprotein E5 variant detected in two French-Canadian subjects
Mailly, F., Xu, C., Xhignesse, M., Lussier-Cacan, S., Talmud, P., Davignon, J., Humphries, S., & Nestruck, A. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42048-6 · Cited by 36
Self-citationApolipoprotein E Gene Polymorphism in Nonalcoholic Fatty Liver Disease
Demirağ, M. D., Önen, H. İ., Karaoğuz, M. Y., Doğan, İ., Karakan, T., Ekmekçi, A., & Güz, G. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9740-5 · Cited by 36
Impact of APOE gene polymorphisms on the lipid profile in an Algerian population
Boulenouar, H., Médiène-Benchekor, S., Meroufel, D. N., Lardjam-Hetraf, S. A., Ouhaïbi-Djellouli, H., Hermant, X., Grenier‐Boley, B., Hamani-Medjaoui, I., Saïdi‐Mehtar, N., Amouyel, P., et al. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-155 · Cited by 36
Prevalence of Prothrombotic Polymorphisms in Greece
Gialeraki, A. E., Politou, M., Rallidis, L. S., Merkouri, E., Markatos, C., Kremastinos, D. T., & Travlou, Α. (2008) · Genetic Testing · doi:10.1089/gte.2008.0060 · Cited by 36
Altenburg, M., Johnson, L., Wilder, J., & Maeda, N. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610712200 · Cited by 34
Baum, L., Ng, H., Wong, K. S., Tomlinson, B., Rainer, T. H., Chen, X., Cheung, W. S., Tang, J.-L., Tam, W., Goggins, W. B., et al. (2006) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2006.047 · Cited by 36
Hopp, L., Gilboa, N., Kurland, G., Weichler, N., & Orchard, T. J. (1994) · Pediatric Nephrology · doi:10.1007/bf00866337 · Cited by 36
Evolutionary Genetics of Coronary Heart Disease
Ding, K., & Kullo, I. J. (2009) · Circulation · doi:10.1161/circulationaha.108.809970 · Cited by 37
The Effect of Apolipoprotein E Polymorphism on Lipid Levels in Korean Adults
Shin, M., Kim, H. N., Cui, L.-H., Kweon, S., Park, K.-S., Heo, H., Nam, H., Jeong, S., Chung, E.-K., & Choi, J. (2005) · Journal of Korean Medical Science · doi:10.3346/jkms.2005.20.3.361 · Cited by 36
Knouff, C., Malloy, S., Wilder, J., Altenburg, M. K., & Maeda, N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009423200 · Cited by 28
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men☆
Kauma, H., Savolainen, M. J., Rantala, A. K., Lilja, M., Kervinen, K., Reunanen, A., & Kesaniemi, Y. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00163-0 · Cited by 36
Scacchi, R., Bernardini, L. D., Mantuano, E., Donini, L. M., Vilardo, T., & Corbo, R. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12190-0 · Cited by 36
Hypertriglyceridemia: Risks and perspectives
Gotto, A. M. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)91086-j · Cited by 37
Lefevre, M., Ginsberg, H. N., Kris‐Etherton, P. M., Elmer, P. J., Stewart, P. W., Ershow, A. G., Pearson, T. A., Roheim, P. S., Ramakrishnan, R., Derr, J., et al. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2914 · Cited by 36
Metadata
- Authors
- Davignon, J., Gregg, R. E., & Sing, C. F.
- Affiliations
- Montreal Clinical Research Institute (CA)
- Venue
- Arteriosclerosis: An Official Journal of the American Heart Association, Inc.
- Published
- 1988-01
- Volume
- 8
- Issue
- 1
- Pages
- 1-21
- ISSN
- 0276-5047 (ISSN-L)
- OpenAlex
- W2066644955
- Cited by
- 1,981
- References
- 98
- Citations by year
- 2026: 10 · 2025: 7 · 2024: 17 · 2023: 10 · 2022: 9 · 2021: 21 · 2020: 21 · 2019: 21 · 2018: 27 · 2017: 28 · 2016: 23 · 2015: 33 · 2014: 31 · 2013: 40 · 2012: 49
- FWCI
- 83.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Arteriosclerosis An Official Journal of the American Heart Association Inc (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL24489, HL-39107)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- APOE polymorphism, atherosclerosis, coronary artery disease, hyperlipidemia, LDL cholesterol, lipoprotein metabolism, gene-environment interaction, type III hyperlipoproteinemia, cardiovascular risk assessment, genetic susceptibility
- MeSH terms
- Alleles, Apolipoproteins, Apolipoproteins E, Arteriosclerosis, Coronary Disease, Humans, Lipids, Lipoproteins, Phenotype, Polymorphism, Genetic, Radiography, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review